These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3109543)

  • 1. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Rossi AC; Hsu JP; Faich GA
    Br Med J (Clin Res Ed); 1987 Jan; 294(6565):147-50. PubMed ID: 3109543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
    Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
    Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.
    Tsong Y
    J Biopharm Stat; 1995 Mar; 5(1):95-114. PubMed ID: 7613562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam in recent epidemiologic studies.
    Bortnichak EA; Sachs RM
    Am J Med; 1986 Nov; 81(5B):44-8. PubMed ID: 3491542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Bortnichak EA; Gordon AJ; Stevens EA
    Br Med J (Clin Res Ed); 1987 May; 294(6582):1289-90. PubMed ID: 3109621
    [No Abstract]   [Full Text] [Related]  

  • 6. Piroxicam-β-cyclodextrin: a GI safer piroxicam.
    Scarpignato C
    Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.
    Conforti A; Leone R; Moretti U; Mozzo F; Velo G
    Drug Saf; 2001; 24(14):1081-90. PubMed ID: 11735663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy.
    Rawson NS
    Ann Pharmacother; 1995; 29(7-8):676-80. PubMed ID: 8520079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulcerogenicity of piroxicam.
    Clinch D
    Br Med J (Clin Res Ed); 1987 Feb; 294(6569):439. PubMed ID: 3101913
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study.
    Illnait J; Terry H; Más R; Fernández L; Carbajal D
    J Med Food; 2005; 8(1):63-8. PubMed ID: 15857212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAIDs and risk of upper gastrointestinal bleeding.
    Henry D; Dobson A; Turner C; Hall P; Forbes C; Patey P
    Lancet; 1991 Mar; 337(8743):730. PubMed ID: 1672190
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathologic condition and prognosis of NSAids ulcer].
    Nishimura S; Uemura N
    Nihon Rinsho; 2011 Jun; 69(6):1003-6. PubMed ID: 21688619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.
    Armstrong CP; Blower AL
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):772. PubMed ID: 3105735
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration.
    Hartnell NR; Wilson JP
    Pharmacotherapy; 2004 Jun; 24(6):743-9. PubMed ID: 15222664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of the restriction in the use piroxicam in Spain.
    Maciá Martínez MÁ
    Reumatol Clin; 2015; 11(6):345-52. PubMed ID: 25636384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and treatment of NSAIDs-induced gastrointestinal complications by prostaglandin derivatives].
    Suzuki Y; Saito E; Wakabayashi T; Suwa A
    Nihon Rinsho; 2007 Oct; 65(10):1843-9. PubMed ID: 17926534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piroxicam and gastrointestinal bleeding.
    Giercksky KE
    Am J Med; 1986 Nov; 81(5B):2-5. PubMed ID: 3491541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.